Reply to A.S. Garden

by Burtness, B., Ferris, R.L, Flamand, Y.
Published 2022

Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment

by Cramer, J.D, Duvvuri, U., Ferris, R.L, Kim, S.
Published 2018

STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV+ status in head and neck cancer

by Concha-Benavente, F., Ferris, R.L, Gibson, S.P, Gooding, W.E, Lu, S., Shayan, G., Srivastava, R.M, Wang, L.
Published 2018

Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort

by Albergotti, W., Andersen, P., Bertolet, M., Clayburgh, D., Duvvuri, U., Ferris, R.L, Geltzeiler, M., Gleysteen, J., Gross, N., Kim, S., Li, R., Olson, B., Persky, M.
Published 2018

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor...

by Blumenschein, G., Jr, Colevas, A.D, Docampo, L.C.I, Even, C., Fayette, J., Ferris, R.L, Gillison, M.L, Guigay, J., Haddad, R., Harrington, K.J, Jayaprakash, V., Kasper, S., Kiyota, N., Li, L., Licitra, L., Lynch, M., Rordorf, T., Saba, N.F, Tahara, M., Vokes, E.E, Worden, F.
Published 2018

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

by Adjei, A.A, Aggarwal, C., Antonia, S., Arnaldez, F.I, Atkinson, V., Baughman, J., Birnbaum, A., Bonvini, E., Cavallo, R., Cohen, R.B, Ferris, R.L, Ganju, V., Goldberg, S.M, Hauke, R., Joshua, A.M, Kalebasty, A.R, Kaul, S., Lakhani, N.J, Lou, Y., Moore, P.A, P Zandberg, D., Peng, L., Prawira, A., Rahma, O., Seetharam, M., Tolcher, A., Vogelzang, N., Weickhardt, A., Zhang, X.
Published 2022